金银花
汤剂
大流行
严重急性呼吸综合征冠状病毒2型(SARS-CoV-2)
2019年冠状病毒病(COVID-19)
H5N1亚型流感病毒
病毒学
传统医学
病毒复制
甲型流感病毒
病毒
冠状病毒
医学
生物
内科学
中医药
病理
替代医学
传染病(医学专业)
疾病
作者
Li-Kun Zhou,Zhen Zhou,Xia-Ming Jiang,Yishan Zheng,Xi Chen,Zheng Fu,Gengfu Xiao,Chen-Yu Zhang,Leike Zhang,Yongxiang Yi
出处
期刊:Cell discovery
[Springer Nature]
日期:2020-08-05
卷期号:6 (1): 54-54
被引量:161
标识
DOI:10.1038/s41421-020-00197-3
摘要
The Coronavirus disease 2019 (COVID-19) pandemic is one of the most serious global public health crises to date. As of July 12, 2020, more than 12.6 million cases of COVID-19 infection with 0.56 million deaths were confirmed worldwide 1 . Since there are no effective therapeutics to treat severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2, the causative virus of COVID-19) infection so far, the pandemic is rapidly spreading worldwide. It is urgent to develop effective therapies, not only to treat infected patients but also to control the pandemic.
科研通智能强力驱动
Strongly Powered by AbleSci AI